Western blot analysis was carried out in order to evaluate new serodiagnostic markers, Em18 and Em16, for differentiation of alveolar echinococcosis (AE) from cystic echinococcosis (CE) using 36 serum samples from hydatid patients from Xinjiang, China, where AE and CE are both endemic and one double infection case has been reported. All AE cases except one (5/6) who exhibited a calcified lesion and a single case of double infection showed antibody responses against Em18 and Em16. Some of CE patient sera (6/22) showed antibody response against Em16 except one who showed that against Em18. Analyses of IgG subclass responses against Em18 and Em16 were carried out us-ing all serum samples showing antibody responses against Em18 and/or Em16 (seven CE, five AE, and one AE+CE) and additional samples of three CE and 22 AE from Sichuan, China. IgG
4 was the most predominant antibody subclass. Em18 and Em16 were recognized by both IgG
4 and IgG
1 (in most cases) or by either IgG
4 or IgG
1 (in minor cases) or by IgG
3 (in very rare cases) . Neither Em18 nor Em16 was recognized by IgG
2 antibodies. The usefulness of Em18 and Em16 as potential new markers for serological differentiation of human AE and CE, respectively, is discussed.
View full abstract